Literature DB >> 16699836

Effect of maternal exposure to homocystine on sodium valproate-induced neural tube defects in the mouse embryos.

R Padmanabhan1, M Shafiullah, S Benedict, N Nagelkerke.   

Abstract

BACKGROUND: Neural tube defects (NTD) are mainly of multifactorial origin. Maternal treatment with valproic acid (VPA) during pregnancy induces NTD in susceptible fetuses. Elevated levels of homocysteine are observed in pregnancies with NTD. The mechanism by which homocysteine might cause NTD is unknown. AIM OF THE STUDY: The aim of this study was to determine if homocystine would augment VPA-induced exencephaly in an experimental model.
METHODS: Groups of mice were injected (IP) on gestational day 8 (GD) with a single dose of 75 mg/kg of L: -Homocystine (HC) or a proportionate volume of saline, followed by a single dose of 600 mg/kg of VPA or an equal volume of saline. In a second experiment, mice were treated with a daily dose of 75 mg/kg of HC or an equal volume of saline (IP) from GD 5 and continued through GD 10. These animals had a single exposure to 600 mg/kg of VPA or saline (IP) on GD 8. All animals were killed by cervical dislocation on GD 18. Plasma homocysteine, folate and vitamin B12 were determined on GD 8 and GD 10 from single and multiple dose groups of mice, respectively, from additional experiments.
RESULTS: The VPA and HC+VPA induced significantly higher rates of embryonic resorption and intrauterine growth retardation (IUGR) than HC or saline alone. HC + VPA groups had significantly more numerous fetuses with severe IUGR than HC alone or VPA alone groups. Both single and multiple doses of HC augmented VPA-induced reduction in fetal body weight. Successive doses of HC did not augment the rate of IUGR more significantly than a single dose of HC. Incidence of exencephaly was significantly enhanced in the HC + VPA groups compared to that in the HC or VPA alone groups. HC alone was not teratogenic. Plasma homocysteine levels increased several fold both in HC and HC + VPA groups and the increase was not particularly more marked in multiple dose groups than in the single dose groups. VPA did not elevate homocysteine concentration. Both FA and vitamin B12 concentrations were reduced by VPA, HC and HC + VPA, but HC and VPA when combined did not produce an additive effect on vitamin levels.
CONCLUSION: These data indicate that HC and VPA interact in neurulation stage embryos, affect fundamental processes of closure of the neural tube and lead to enhanced incidence of NTD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16699836     DOI: 10.1007/s00394-006-0600-4

Source DB:  PubMed          Journal:  Eur J Nutr        ISSN: 1436-6207            Impact factor:   5.614


  41 in total

1.  Incidence of neural tube defects in the least-developed area of India: a population-based study.

Authors:  Anil Cherian; Siju Seena; Robyn K Bullock; Aśok C Antony
Journal:  Lancet       Date:  2005 Sep 10-16       Impact factor: 79.321

2.  Effect of chronic valproate treatment on folate-dependent methyl biosynthesis in the rat.

Authors:  G F Carl
Journal:  Neurochem Res       Date:  1986-05       Impact factor: 3.996

3.  [Should folic acid be given to women treated with valproic acid and/or carbamazepine? Folic acid and pregnancy in epilepsy].

Authors:  V Champel; M Radal; M Moulin-Vallez; A P Jonville-Béra; E Autret-Leca
Journal:  Rev Neurol (Paris)       Date:  1999-03       Impact factor: 2.607

4.  Lack of embryotoxicity of homocysteine thiolactone in mouse embryos in vitro.

Authors:  D K Hansen; T F Grafton; S Melnyk; S J James
Journal:  Reprod Toxicol       Date:  2001 May-Jun       Impact factor: 3.143

5.  Pharmacology of neural tube defects.

Authors:  C E Pippenger
Journal:  Epilepsia       Date:  2003       Impact factor: 5.864

6.  Serum amino acids, liver status, and antiepileptic drug therapy in epilepsy.

Authors:  M L Rao; H Stefan; C Scheid; A D Kuttler; W Fröscher
Journal:  Epilepsia       Date:  1993 Mar-Apr       Impact factor: 5.864

7.  Apparent prevention of neural tube defects by periconceptional vitamin supplementation.

Authors:  R W Smithells; S Sheppard; C J Schorah; M J Seller; N C Nevin; R Harris; A P Read; D W Fielding
Journal:  Arch Dis Child       Date:  1981-12       Impact factor: 3.791

8.  Embryonic development of folate binding protein-1 (Folbp1) knockout mice: Effects of the chemical form, dose, and timing of maternal folate supplementation.

Authors:  Ofer Spiegelstein; Laura E Mitchell; Michelle Y Merriweather; Ned J Wicker; Qiang Zhang; Edward J Lammer; Richard H Finnell
Journal:  Dev Dyn       Date:  2004-09       Impact factor: 3.780

Review 9.  Epidemiology of neural tube defects.

Authors:  Lauren Frey; W Allen Hauser
Journal:  Epilepsia       Date:  2003       Impact factor: 5.864

10.  L-Homocysteine and L-homocystine stereospecifically induce endothelial nitric oxide synthase-dependent lipid peroxidation in endothelial cells.

Authors:  Stanley J Heydrick; Norbert Weiss; Shane R Thomas; Andre P Cap; David R Pimentel; Joseph Loscalzo; John F Keaney
Journal:  Free Radic Biol Med       Date:  2004-03-01       Impact factor: 7.376

View more
  4 in total

1.  Ameliorative effects of supplemental folinic acid on Lamotrigine-induced fetal malformations in the mouse.

Authors:  Y M Abdulrazzaq; M Shafiullah; J Kochyil; R Padmanabhan; S M A Bastaki
Journal:  Mol Cell Biochem       Date:  2018-01-23       Impact factor: 3.396

2.  Interferon regulatory factor-1 binds c-Cbl, enhances mitogen activated protein kinase signaling and promotes retinoic acid-induced differentiation of HL-60 human myelo-monoblastic leukemia cells.

Authors:  Miaoqing Shen; Rodica P Bunaciu; Johanna Congleton; Holly A Jensen; Lavanya G Sayam; Jeffrey D Varner; Andrew Yen
Journal:  Leuk Lymphoma       Date:  2011-08-24

3.  Valproic acid increases expression of methylenetetrahydrofolate reductase (MTHFR) and induces lower teratogenicity in MTHFR deficiency.

Authors:  Marc Roy; Daniel Leclerc; Qing Wu; Sapna Gupta; Warren D Kruger; Rima Rozen
Journal:  J Cell Biochem       Date:  2008-10-01       Impact factor: 4.429

4.  Anticonvulsant and reproductive toxicological studies of the imidazole-based histamine H3R antagonist 2-18 in mice.

Authors:  Salim M Bastaki; Yousef M Abdulrazzaq; Mohamed Shafiullah; Małgorzata Więcek; Katarzyna Kieć-Kononowicz; Bassem Sadek
Journal:  Drug Des Devel Ther       Date:  2018-01-19       Impact factor: 4.162

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.